UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $186.48 Million Holdings in Waters Co. (NYSE:WAT)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Waters Co. (NYSE:WAT - Free Report) by 5.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 502,679 shares of the medical instruments supplier's stock after purchasing an additional 25,535 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.85% of Waters worth $186,484,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. Aster Capital Management DIFC Ltd acquired a new position in Waters during the fourth quarter worth $28,000. Bank of Jackson Hole Trust bought a new position in Waters in the fourth quarter valued at about $34,000. Steward Partners Investment Advisory LLC boosted its holdings in Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 53 shares during the last quarter. Murphy & Mullick Capital Management Corp bought a new position in Waters in the fourth quarter valued at about $42,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in Waters by 54.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock valued at $46,000 after acquiring an additional 44 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

WAT has been the topic of several recent research reports. Wall Street Zen upgraded Waters from a "hold" rating to a "buy" rating in a report on Thursday. Wells Fargo & Company raised their target price on Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. KeyCorp upgraded Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 target price on the stock in a report on Monday, March 31st. Scotiabank raised Waters from a "sector perform" rating to a "sector outperform" rating and raised their price target for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. Finally, Baird R W raised Waters from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 26th. Nine investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Waters presently has an average rating of "Moderate Buy" and a consensus target price of $390.19.

Waters Price Performance

Shares of WAT opened at $348.01 on Friday. Waters Co. has a 12-month low of $279.24 and a 12-month high of $423.56. The business has a 50-day simple moving average of $345.15 and a two-hundred day simple moving average of $370.83. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. The stock has a market cap of $20.71 billion, a PE ratio of 32.49, a PEG ratio of 3.79 and a beta of 1.14.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.22 by $0.03. The business had revenue of $661.71 million during the quarter, compared to analysts' expectations of $655.50 million. Waters had a return on equity of 46.31% and a net margin of 21.56%. The business's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.21 EPS. Analysts anticipate that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.